Lewis Asset Management »

Adaptive Biotechnologies Cor shares owned by Lewis Asset Management

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Lewis Asset Management from 13F filings

Historical chart of Lewis Asset Management investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Lewis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Lewis Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $96k 20k 4.90

More positions owned by Lewis Asset Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Spdr Ser Tr S&p Divid Etf (SDY)
Rithm Capital Corp Com New (RITM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Cap Stk Cl C (GOOG)
Atlassian Corporation Cl A (TEAM)
Angel Oak Funds Trust Oak Ultrashort (UYLD)
salesforce (CRM)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Abbvie (ABBV)

View all positions for Lewis Asset Management

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
Vanguard Group
ARK Investment Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Point72 Asset Management
Massachusetts Financial Services
Dimensional Fund Advisors
Blue Water Life Science Advisors
Braidwell
Gilder, Gagnon, Howe & Co
Eagle Health Investments
Federated Investors
Standard Life Aberdeen
Nordea Investment Management Ab

View all funds holding Adaptive Biotechnologies Cor